pirtobrutinib
Tyrosine Kinase Inhibitors
Common brand names
- Jaypirca
Approved use in
- Chronic Lymphocytic Leukemia
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma
Information about use in Blood Cancer
Information about use in Chronic Lymphocytic Leukemia
Information about use in Mantle Cell Lymphoma
Information about use in Marginal Zone Lymphoma